Investigative Ophthalmology & Visual Science Cover Image for Volume 61, Issue 7
June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
Peptide Inhibitor of MyD88 Increases Neuroprotective Microglia and Photoreceptor Survival
Author Affiliations & Notes
  • Andrea Nortey
    Bascom Palmer Eye Institute, Miami, Florida, United States
  • Kimberly Garces
    Bascom Palmer Eye Institute, Miami, Florida, United States
  • Tal Carmy
    Bascom Palmer Eye Institute, Miami, Florida, United States
  • Ciara Myer
    Bascom Palmer Eye Institute, Miami, Florida, United States
  • Sanjoy K Bhattacharya
    Bascom Palmer Eye Institute, Miami, Florida, United States
  • Abigail Hackam
    Bascom Palmer Eye Institute, Miami, Florida, United States
  • Footnotes
    Commercial Relationships   Andrea Nortey, None; Kimberly Garces, None; Tal Carmy, None; Ciara Myer, None; Sanjoy Bhattacharya, None; Abigail Hackam, None
  • Footnotes
    Support  Institutional support to BPEI was from a Research to Prevent Blindness Unrestricted Grant and an NEI Center Core Grant EY014801; Foundation Fighting Blindness; NEI R01 EY026546; U.S. Department of Defense (WHX81-16-0715)
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 1296. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Andrea Nortey, Kimberly Garces, Tal Carmy, Ciara Myer, Sanjoy K Bhattacharya, Abigail Hackam; Peptide Inhibitor of MyD88 Increases Neuroprotective Microglia and Photoreceptor Survival. Invest. Ophthalmol. Vis. Sci. 2020;61(7):1296.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Myeloid differentiation factor 88 (MyD88) is an adaptor protein for Toll-like receptors and interleukin 1 receptors that mediates inflammatory responses to cellular injury through cytokine release and migration of microglia and macrophages to injury sites. MyD88 also regulates microglia polarization into neurotoxic or neuroprotective phenotypes. In this study, we investigated the consequences of inhibiting MyD88 signaling early in retinal degeneration.

Methods : Rd10 mice (Jackson Labs) were randomly divided into therapeutic and experimental groups and injected IP with 1, 2, or 3 mg/Kg body weight of MyD88 inhibitor (MI) or control peptides (Ctrl) (Novus Biologicals). Retina function was analyzed by ERGs, microglia/macrophage were quantified by immunostaining for IBA1 and Arg1 and flow cytometry, cytokine levels were quantified by cytoplex, and iTRAQ labeling for mass spectrometry based proteomic quantification used a Q Exactive instrument.

Results : 2 mg/Kg MI injected mice showed 3.7 fold (p=0.018) and 3 fold (p=0.024) decrease in apoptotic retinal cells compared to Ctrl and untreated rd10 mice, respectively. ERGs showed significantly higher scotopic responses in 2 mg/Kg MI injected mice compared to Ctrl or untreated mice (p<0.05). We demonstrated that the number of CD45highCD11b+ macrophages and CD45lowCD11b+ microglia in the retina did not differ between MI and Ctrl injected mice. However, IBA1+ cells in the ONL were reduced by half in MI injected mice compared with Ctrl (p=0.0254), suggesting reduced macrophage/microglia migration contributes to an anti-inflammatory environment. Furthermore, there were 2-fold more IBA1+ cells that were positive for the Arg1 marker of neuroprotective microglia (p=0.0058) in the MI injected mice. Cytokine analysis demonstrated that the anti-inflammatory cytokine IL-27 was significantly higher in MI injected mice compared with Ctrl (p=0.03), and intraocular injection of IL-27 into rd10 mice significantly increased photopic and scotopic ERG responses (p<0.05). Finally, proteomics analysis demonstrated upregulation of multiple anti-apoptotic chaperone proteins in MI injected mouse retinas.

Conclusions : Inhibiting MyD88 led to increased photoreceptor survival, which was associated with increased polarization into Arg+ neuroprotective microglia. Potential neuroprotective mechanisms involved increased IL-27 and chaperones.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×